{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:03:57Z","timestamp":1759935837966,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["P01AI082325"],"award-info":[{"award-number":["P01AI082325"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.virol.2012.01.025","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T01:39:31Z","timestamp":1329356371000},"page":"120-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A role for granulocyte\u2013macrophage colony-stimulating factor in the regulation of CD8+ T cell responses to rabies virus"],"prefix":"10.1016","volume":"426","author":[{"given":"Celestine N.","family":"Wanjalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth F.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2012.01.025_bb0005","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2567.2004.01920.x","article-title":"Cross-presentation: dendritic cells and macrophages bite off more than they can chew!","volume":"112","author":"Brode","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.virol.2012.01.025_bb0015","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V96.12.3838","article-title":"Identification of a CD11b(+)\/Gr-1(+)\/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells","volume":"96","author":"Bronte","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.virol.2012.01.025_bb0020","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1128\/JVI.75.24.12128-12140.2001","article-title":"Granulocyte\u2013macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells","volume":"75","author":"Bukreyev","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0025","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/S0021-9258(18)71855-3","article-title":"Purification and properties of colony-stimulating factor from mouse lung-conditioned medium","volume":"252","author":"Burgess","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2012.01.025_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02113594","article-title":"Granulocyte\u2013macrophage colony-stimulating factor given as an adjuvant to persons not responding to hepatitis B vaccine","volume":"25","author":"Carlsson","year":"1997","journal-title":"Infection"},{"key":"10.1016\/j.virol.2012.01.025_bb0035","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"Cenna","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.01.025_bb0040","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte\u2013macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2012.01.025_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"Faul","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.01.025_bb0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2009.10.051","article-title":"Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge","volume":"28","author":"Faul","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.01.025_bb0055","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/JVI.01870-09","article-title":"Characterization of a single-cycle rabies virus-based vaccine vector","volume":"84","author":"Gomme","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0060","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2012.01.025_bb0065","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2012.01.025_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2001.19.1.145","article-title":"Novel allogeneic granulocyte\u2013macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation","volume":"19","author":"Jaffee","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.virol.2012.01.025_bb0075","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.gt.3303026","article-title":"Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy","volume":"14","author":"Janke","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2012.01.025_bb0080","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2012.01.025_bb0085","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood-2008-02-140681","article-title":"Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors","volume":"112","author":"Kared","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.virol.2012.01.025_bb0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1006\/cyto.2000.0684","article-title":"Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen-presenting cells in regional lymph nodes","volume":"12","author":"Kass","year":"2000","journal-title":"Cytokine"},{"year":"2007","series-title":"Kuby Immunology","author":"Kindt","key":"10.1016\/j.virol.2012.01.025_bb0095"},{"key":"10.1016\/j.virol.2012.01.025_bb0100","doi-asserted-by":"crossref","first-page":"e11021","DOI":"10.1371\/journal.pone.0011021","article-title":"GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates","volume":"5","author":"Loudon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2012.01.025_bb0105","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.4049\/jimmunol.169.11.6324","article-title":"GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis","volume":"169","author":"Lu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2012.01.025_bb0110","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1200\/JCO.2005.01.6816","article-title":"Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients","volume":"23","author":"Luiten","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.virol.2012.01.025_bb0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","article-title":"Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma","volume":"6","author":"Mastrangelo","year":"1999","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virol.2012.01.025_bb0135","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0125","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) Gag\u2013Pol or HIV-1 Gag\u2013Pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"McGettigan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.virol.2005.09.004","article-title":"Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2","volume":"344","author":"McGettigan","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.01.025_bb0140","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"Mebatsion","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2012.01.025_bb0145","first-page":"427","article-title":"Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels","volume":"21","author":"Metcalf","year":"1971","journal-title":"Immunology"},{"key":"10.1016\/j.virol.2012.01.025_bb0150","first-page":"323","article-title":"Molecular control of granulocyte and macrophage production","volume":"191","author":"Metcalf","year":"1985","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.virol.2012.01.025_bb0155","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood.V93.5.1579.405k01_1579_1585","article-title":"Receptor clearance obscures the magnitude of granulocyte\u2013macrophage colony-stimulating factor responses in mice to endotoxin or local infections","volume":"93","author":"Metcalf","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.virol.2012.01.025_bb0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/annonc\/mdl158","article-title":"Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients","volume":"18","author":"Parmiani","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.virol.2012.01.025_bb0165","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1128\/JVI.00084-06","article-title":"Immunogenicity of cytopathic and noncytopathic viral vectors","volume":"80","author":"Plesa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0170","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1128\/JVI.79.24.15043-15053.2005","article-title":"A vesicular stomatitis virus recombinant expressing granulocyte\u2013macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals","volume":"79","author":"Ramsburg","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.virol.2012.01.025_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2012.01.025_bb0185","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1158\/0008-5472.CAN-04-0757","article-title":"High-dose granulocyte\u2013macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells","volume":"64","author":"Serafini","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2012.01.025_bb0190","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","article-title":"Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology","volume":"91","author":"Stanley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2012.01.025_bb0195","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/eji.200737400","article-title":"Dendritic cells: understanding immunogenicity","volume":"37","author":"Steinman","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2012.01.025_bb0205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virol.2012.01.025_bb0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2012.01.025_bb0210","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.4049\/jimmunol.170.11.5511","article-title":"Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+\/CD25+ T cells and suppresses experimental autoimmune thyroiditis","volume":"170","author":"Vasu","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2012.01.025_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vaccine.2010.08.042","article-title":"Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity","volume":"29","author":"Wanjalla","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.01.025_bb0220","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.01552-10","article-title":"Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination","volume":"85","author":"Wen","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/JVI.01309-10","article-title":"Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV","volume":"85","author":"Wirblich","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.01.025_bb0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1348-0421.2006.tb03773.x","article-title":"Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses","volume":"50","author":"Yoon","year":"2006","journal-title":"Microbiol. Immunol."},{"issue":"8","key":"10.1016\/j.virol.2012.01.025_bb0235","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:15:45Z","timestamp":1758586545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682212000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0042682212000621"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.01.025","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role for granulocyte\u2013macrophage colony-stimulating factor in the regulation of CD8+ T cell responses to rabies virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}